News
-
-
-
COMMUNIQUÉ DE PRESSE
Sonnet BioTherapeutics (NASDAQ:SONN) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
JTC Team releases 'What This Means' segment featuring Sonnet BioTherapeutics discussing encouraging data from ongoing clinical trial. Virtual presentation available now -
-
-
COMMUNIQUÉ DE PRESSE
Final Participating Company Line-Up Announced for the Virtual Investor Pitch Conference Hosted by JTC Team Being Held June 17 - 18, 2024
JTC announces final line-up for Virtual Investor Pitch Conference on June 17-18, 2024, featuring live webcast presentations by various companies at www.virtualinvestorco.com -
-
-
-
BRÈVE
L'équipe JTC annonce la liste des entreprises participantes à la conférence virtuelle de présentation des investisseurs les 17 et 18 juin 2024
Relations Avec Les Investisseurs Webdiffusion En Direct Conférence Virtuelle Événements Financiers L'équipe JTC 10 H 00 HE : Adolore BioTherapeutics – Webdiffusion 11 H 00 HE : CNS Pharmaceuticals, Inc. – Webdiffusion 12h00 HE : Palisade Bio, Inc. – Webdiffusion 13 H HE : AIM ImmunoTech Inc. – Webdiffusion 16 H 00 HE : EnVVeno Medical Corporation – Webdiffusion 10 H 00 HE : Royalty Management Holding Corporation – Webdiffusion 11 H 00 HE : GRI Bio, Inc. – Webdiffusion 12 H 00 HE : Outlook Therapeutics, Inc. – Webdiffusion 13 H 00 HE : American Resources Corporation – Webdiffusion 15 H 00 HE : Moleculin Biotech, Inc. – Webdiffusion
